Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Conventional chemotherapy faces challenges with side effects and multidrug resistance.
• Nanomedicines offer potential for tumor-targeted therapy but face in vivo limitations like poor barrier crossing and off-target effects.

Purpose of the Study:

• To review recent advances in bioinspired and biomimetic nanomedicines for targeted cancer therapy.
• To discuss the integration of biological materials with synthetic nanoparticles for enhanced therapeutic outcomes.
• To analyze the impact of biological components and synthetic materials on nanomedicine efficacy and targeting.

Main Methods:

• Review of current literature on mammalian cell-based and pathogen-based nanomedicine systems.
• Analysis of strategies for improving nanomedicine biocompatibility, circulation time, tumor targeting, and immune modulation.
• Discussion of the interplay between nanomedicine design and biological interactions.

Main Results:

• Biomimetic nanomedicines demonstrate enhanced biocompatibility and tumor accumulation.
• Utilizing mammalian cells and pathogens as components improves nanoparticle functionality for cancer therapy.
• Bioinspired designs show promise in overcoming in vivo barriers and off-target effects.

Conclusions:

• Biomimetic nanomedicines represent a promising frontier in cancer treatment, maximizing anti-tumor efficacy while minimizing adverse effects.
• The strategic incorporation of biological materials into nanomedicine platforms is crucial for overcoming current therapeutic limitations.
• Further research into the biological influences and limitations of synthetic materials is essential for optimizing nanomedicine development.